|
|
||||||||
Published online before print January 2, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

T-lymphocytes. Response to isopentenyl pyrophosphate and TGF-ß1/IL-15
University Medical Clinic I, Department of Pneumology and Allergy/Immunology, Friedrich-Schiller-University Jena, Germany
1Correspondence: Pneumology, Medical Clinic I, Friedrich-Schiller-University Jena, Erlanger Allee 101, 07740 Jena, Germany. E-mail: grefachew.workalemahu{at}med.uni-jena.de

T-lymphocytes are believed to play a role in maintaining the normal configuration of epithelial tissue. As little is known about the factors mediating this function, we addressed the question of whether 
T-lymphocytes produce fibroblast growth factor (FGF)-9 as well as two other growth factors associated with epithelial tissue reconstitution. Blood 
T cells isolated from healthy donors were grown in the presence of isopentenyl pyrophosphate (IPP) or transforming growth factor-ß1 (TGF-ß1)/interleukin-15 (IL-15) for 24 h and were assessed for the expression and synthesis of FGF-9, keratinocyte growth factor (KGF), and epidermal growth factor (EGF). Resting human 
T cells constitutively expressed KGF and FGF-9 mRNA but no EGF mRNA. In the presence of IPP, FGF-9 mRNA expression significantly increased in a dose-dependent manner, expression of KGF remained unaltered, and EGF mRNA could not be detected. In contrast to IPP, stimulation of the cells with TGF-ß1/IL-15 did not alter FGF-9 expression. Moreover, stimulation with anti-CD3 does not induce FGF-9 expression but triggers a high signal of interferon-
mRNA. Western blot analysis of 
T cell lysates, prepared 4 days following stimulation with IPP, showed an increase of FGF-9 protein as compared with control cells. In conclusion, the results demonstrate for the first time that human blood and bronchoalveolar lavage 
T-lymphocytes are capable of expressing FGF-9. The data also provide novel evidence that immunoregulatory cells can synthesize FGF-9.
Key Words: growth factors bacterial peptide IPP
This article has been cited by other articles:
![]() |
Y. Omoto Estrogen Receptor-{alpha} Signaling in Growth of the Ventral Prostate: Comparison of Neonatal Growth and Postcastration Regrowth Endocrinology, September 1, 2008; 149(9): 4421 - 4427. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kagimoto, H. Yamada, T. Ishikawa, N. Maeda, F. Goshima, Y. Nishiyama, M. Furue, and Y. Yoshikai A regulatory role of interleukin 15 in wound healing and mucosal infection in mice J. Leukoc. Biol., January 1, 2008; 83(1): 165 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-J. Puan, C. Jin, H. Wang, G. Sarikonda, A. M. Raker, H. K. Lee, M. I. Samuelson, E. Marker-Hermann, L. Pasa-Tolic, E. Nieves, et al. Preferential recognition of a microbial metabolite by human V{gamma}2V{delta}2 T cells Int. Immunol., May 1, 2007; 19(5): 657 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kabelitz, D. Wesch, E. Pitters, and M. Zoller Characterization of Tumor Reactivity of Human V{gamma}9V{delta}2 {gamma}{delta} T Cells In Vitro and in SCID Mice In Vivo J. Immunol., December 1, 2004; 173(11): 6767 - 6776. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |